Mankind setting up Rs 300-crore unit to manufacture fertility hormone

Mankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The unit will manufacture dydrogesterone key starting materials, active pharmaceutical ingredients (API) and formulations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9gC1R8M
via IFTTT